Ingelheim, Germany

Heinz-Peter Schmitt



 

Average Co-Inventor Count = 6.5

ph-index = 4

Forward Citations = 31(Granted Patents)


Location History:

  • Ingelheim, DE (2007 - 2011)
  • Ingelheim and Rhein, DE (2013)
  • Ingelheim am Rhein, DE (2015)

Company Filing History:


Years Active: 2007-2015

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Heinz-Peter Schmitt

Introduction

Heinz-Peter Schmitt is a notable inventor based in Ingelheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of corticosteroids. With a total of 5 patents to his name, Schmitt's work has had a considerable impact on respiratory treatments.

Latest Patents

One of Schmitt's latest patents is a method for manufacturing ciclesonide. This invention relates to a process for preparing the corticosteroid ciclesonide, which is used for the treatment of respiratory complaints, in epimerically pure form. Another significant patent is for the process of preparing 4-(benzimidazolylmethylamino)-benzamides and the salts thereof. This invention focuses on a process for preparing an optionally substituted 4-benzimidazol-2-ylmethylamino)-benzamidine.

Career Highlights

Throughout his career, Schmitt has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. His work in these organizations has allowed him to contribute to the advancement of medical treatments.

Collaborations

Heinz-Peter Schmitt has collaborated with several professionals in his field, including Georg Zerban and Arndt Hausherr. These collaborations have further enriched his research and development efforts.

Conclusion

Heinz-Peter Schmitt's innovative work in the pharmaceutical industry has led to significant advancements in respiratory treatments. His contributions continue to influence the field and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…